Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial
LungenClinic Grosshansdorf · Regional Clinical Hospital named after II Mechnikov · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
609
total citations
- FWCI
- 23.56
- Percentile
- 100%
- References
- 46
Citations per year
Authors
10Topics & keywords
Topics
Keywords
- Ipilimumab
- Medicine
- Carboplatin
- Internal medicine
- Oncology
- Placebo
- Clinical endpoint
- Cancer
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.